{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:45:35Z","timestamp":1773074735794,"version":"3.50.1"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T00:00:00Z","timestamp":1414540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12094-014-1236-0","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T16:47:22Z","timestamp":1414514842000},"page":"90-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Genetic modification of hypoxia signaling in animal models and its effect on cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"J. M.","family":"Garc\u00eda-Heredia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Felipe-Abrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carnero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,29]]},"reference":[{"key":"1236_CR1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/cphy.c120030","volume":"3","author":"TL Clanton","year":"2013","unstructured":"Clanton TL, Hogan MC, Gladden LB. Regulation of cellular gas exchange, oxygen sensing and metabolic control. Compr Physiol. 2013;3:1135\u201390.","journal-title":"Compr Physiol."},{"key":"1236_CR2","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1101\/gad.1145503","volume":"17","author":"RK Bruick","year":"2003","unstructured":"Bruick RK. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev. 2003;17:2614\u201323.","journal-title":"Genes Dev."},{"key":"1236_CR3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/cbf.2985","volume":"31","author":"AB Zepeda","year":"2013","unstructured":"Zepeda AB, Pessoa A, Castillo RL, Figueroa CA, Pulgar VM, Far\u00edas JG. Cellular and molecular mechanisms in the hypoxic tissue: role of HIF-1 and ROS. Cell Biochem Funct. 2013;31:451\u20139.","journal-title":"Cell Biochem Funct."},{"key":"1236_CR4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","volume":"5","author":"CJ Schofield","year":"2004","unstructured":"Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 2004;5:343\u201354.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1236_CR5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cardiores.2006.05.005","volume":"71","author":"J Fandrey","year":"2006","unstructured":"Fandrey J, Gorr TA, Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc Res. 2006;71:642\u201351.","journal-title":"Cardiovasc Res."},{"key":"1236_CR6","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;92:5510\u20134.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1236_CR7","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1242\/jcs.117564","volume":"126","author":"K Janke","year":"2013","unstructured":"Janke K, Brockmeier U, Kuhlmann K, Eisenacher M, Nolde J, Meyer HE, et al. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2). J Cell Sci. 2013;126:2629\u201340.","journal-title":"J Cell Sci."},{"key":"1236_CR8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393\u2013402.","journal-title":"Mol Cell."},{"key":"1236_CR9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell. 2010;40:294\u2013309.","journal-title":"Mol Cell."},{"key":"1236_CR10","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00018-011-0679-5","volume":"68","author":"M Heikkil\u00e4","year":"2011","unstructured":"Heikkil\u00e4 M, Pasanen A, Kivirikko KI, Myllyharju J. Roles of the human hypoxia-inducible factor (HIF)-3\u03b1 variants in the hypoxia response. Cell Mol Life Sci. 2011;68:3885\u2013901.","journal-title":"Cell Mol Life Sci."},{"key":"1236_CR11","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","volume":"294","author":"RK Bruick","year":"2001","unstructured":"Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001;294:1337\u201340.","journal-title":"Science."},{"key":"1236_CR12","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1101\/gad.924501","volume":"15","author":"PC Mahon","year":"2001","unstructured":"Mahon PC, Hirota K, Semenza GL. FIH: a novel protein that interacts with HIF-1\u03b1 and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001;15:2674\u201386.","journal-title":"Genes Dev."},{"key":"1236_CR13","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1113\/jphysiol.2013.251470","volume":"591","author":"PJ Ratcliffe","year":"2013","unstructured":"Ratcliffe PJ. Oxygen sensing and hypoxia signaling pathways in animals: the implications of physiology for cancer. J Physiol. 2013;591:2027\u201342.","journal-title":"J Physiol."},{"key":"1236_CR14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/apha.12096","volume":"208","author":"J Myllyharju","year":"2013","unstructured":"Myllyharju J. Prolyl-4-hydroxylases, master regulators of the hypoxia response. Acta Physiol. 2013;208:148\u201365.","journal-title":"Acta Physiol."},{"key":"1236_CR15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.cmet.2010.03.001","volume":"11","author":"N Zhang","year":"2010","unstructured":"Zhang N, Fu Z, Linke S, Chicher J, Gorman JJ, Visk D, et al. The asparaginyl hydroxylase factor inhibiting HIF-1\u03b1 is an essential regulator of metabolism. Cell Metab. 2010;11:364\u201378.","journal-title":"Cell Metab."},{"key":"1236_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factor for oxygen-dependent proteolysis. Nature. 1999;399:271\u20135.","journal-title":"Nature."},{"key":"1236_CR17","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1101\/gad.991402","volume":"16","author":"D Lando","year":"2002","unstructured":"Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002;16:1466\u201371.","journal-title":"Genes Dev."},{"key":"1236_CR18","first-page":"187","volume":"2","author":"LMA Crane","year":"2010","unstructured":"Crane LMA, Hesselink JW, Zeebregts CJAM, Francis KP, de Jong JS, van Dam GM. Animal models of esophageal cancer and hypoxia: an overview of applications, possibilities and limitations. Glob J Biochem. 2010;2:187\u2013204.","journal-title":"Glob J Biochem."},{"key":"1236_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2009.10.009","volume":"20","author":"GL Semenza","year":"2010","unstructured":"Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev. 2010;20:51\u20136.","journal-title":"Curr Opin Genet Dev."},{"key":"1236_CR20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","volume":"29","author":"GL Semenza","year":"2010","unstructured":"Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010;29:625\u201334.","journal-title":"Oncogene."},{"key":"1236_CR21","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-10-1206","volume":"16","author":"EE Graves","year":"2010","unstructured":"Graves EE, Vilalta M, Cecik IK, Erler JT, Tran PT, Felsher D, et al. Hypoxia in models of lung cancer: implications for targeted therapeutics. Clin Cancer Res. 2010;16:4843\u201352.","journal-title":"Clin Cancer Res."},{"key":"1236_CR22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0975-7406.124301","volume":"6","author":"TF Vandamme","year":"2014","unstructured":"Vandamme TF. Use of rodents as models of human diseases. J Pharm Bioallied Sci. 2014;6:2\u20139.","journal-title":"J Pharm Bioallied Sci."},{"key":"1236_CR23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrc2192","volume":"7","author":"KK Frese","year":"2007","unstructured":"Frese KK, Tuveson DA. Maximizing mouse cancer models. Nat Rev Cancer. 2007;7:645\u201358.","journal-title":"Nat Rev Cancer."},{"key":"1236_CR24","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1530\/ERC-12-0285","volume":"20","author":"X Wu","year":"2013","unstructured":"Wu X, Gong S, Roy-Burman P, Lee P, Culig Z. Current mouse and cell models in prostate cancer research. Endocr Relat Cancer. 2013;20:R155\u201370.","journal-title":"Endocr Relat Cancer."},{"key":"1236_CR25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10162-012-0324-5","volume":"13","author":"BC Cox","year":"2012","unstructured":"Cox BC, Liu Z, Mellado-Lagarde MM, Zuo J. Conditional gene expression in the mouse inner ear using Cre-loxP. J Assoc Res Otolaryngol. 2012;13:295\u2013322.","journal-title":"J Assoc Res Otolaryngol."},{"key":"1236_CR26","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1158\/0008-5472.CAN-11-1745","volume":"71","author":"L Fu","year":"2011","unstructured":"Fu L, Wang G, Shevchuk MM, Nanus DM, Gudas LJ. Generation of a mouse model of von Hippel\u2013Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1\u03b1. Cancer Res. 2011;71:6848\u201356.","journal-title":"Cancer Res."},{"key":"1236_CR27","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1073\/pnas.1320243111","volume":"111","author":"GO Ahn","year":"2014","unstructured":"Ahn GO, Seita J, Hong BJ, Kim YE, Bok S, Lee CJ, et al. Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8. Proc Natl Acad Sci USA. 2014;111:2698\u2013703.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1236_CR28","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","volume":"95","author":"LE Huang","year":"1998","unstructured":"Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1\u03b1 is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 1998;95:7987\u201392.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1236_CR29","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1096\/fj.00-0732fje","volume":"15","author":"UR Jewell","year":"2001","unstructured":"Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, Gassmann M. Induction of HIF-1\u03b1 in response to hypoxia is instantaneous. FASEB J. 2001;15:1312\u20134.","journal-title":"FASEB J."},{"key":"1236_CR30","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/MCB.00718-13","volume":"34","author":"Z Chen","year":"2014","unstructured":"Chen Z, Liu X, Mei Z, Wang Z, Xiao W. EAF2 suppresses hypoxia-induced factor 1\u03b1 transcriptional activity by disrupting its interaction with coactivator CBP\/p300. Mol Cell Biol. 2014;34:1085\u201399.","journal-title":"Mol Cell Biol."},{"key":"1236_CR31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","volume":"29","author":"A Loboda","year":"2010","unstructured":"Loboda A, Jozkowicz A, Dulak J. HIF-1 and HIF-2 transcription factors\u2014similar but not identical. Mol Cells. 2010;29:435\u201342.","journal-title":"Mol Cells."},{"key":"1236_CR32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/cdd.2008.17","volume":"15","author":"SA Patel","year":"2008","unstructured":"Patel SA, Simon MC. Biology of hypoxia-inducible factor-2\u03b1 in development and disease. Cell Death Differ. 2008;15:628\u201334.","journal-title":"Cell Death Differ."},{"key":"1236_CR33","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1074\/jbc.275.7.4618","volume":"275","author":"D Lando","year":"2000","unstructured":"Lando D, Pongratz I, Poellinger L, Whitelaw ML. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1\u03b1 and the HIF-like factor. J Biol Chem. 2000;275:4618\u201327.","journal-title":"J Biol Chem."},{"key":"1236_CR34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/cdd.2008.21","volume":"15","author":"EB Rankin","year":"2008","unstructured":"Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 2008;15:678\u201385.","journal-title":"Cell Death Differ."},{"key":"1236_CR35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/35107085","volume":"414","author":"Y Makino","year":"2001","unstructured":"Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature. 2001;414:550\u20134.","journal-title":"Nature."},{"key":"1236_CR36","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","volume":"17","author":"HE Ryan","year":"1998","unstructured":"Ryan HE, Lo J, Johnson RS. HIF-1\u03b1 is required for solid tumor formation and embryonic vascularization. EMBO J. 1998;17:3005\u201315.","journal-title":"EMBO J."},{"key":"1236_CR37","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1101\/gad.12.21.3320","volume":"12","author":"H Tian","year":"1998","unstructured":"Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 1998;12:3320\u20134.","journal-title":"Genes Dev."},{"key":"1236_CR38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/dbio.1999.9253","volume":"209","author":"LE Kotch","year":"1999","unstructured":"Kotch LE, Iyer NV, Laughner E, Semenza GL. Defective vascularization of HIF-1\u03b1-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol. 1999;209:254\u201367.","journal-title":"Dev Biol."},{"key":"1236_CR39","first-page":"4010","volume":"60","author":"HE Ryan","year":"2000","unstructured":"Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, et al. Hypoxia-inducible factor-1\u03b1 is a positive factor in solid tumor growth. Cancer Res. 2000;60:4010\u20135.","journal-title":"Cancer Res."},{"key":"1236_CR40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1476-4598-9-133","volume":"9","author":"O M\u00e9ndez","year":"2010","unstructured":"M\u00e9ndez O, Zavadil J, Esencay M, Lukyanov Y, Santovasi D, Wang SH, et al. Knock down of HIF-1\u03b1 in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol Cancer. 2010;9:133.","journal-title":"Mol Cancer."},{"key":"1236_CR41","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/srep00494","volume":"2","author":"T Takeda","year":"2012","unstructured":"Takeda T, Okuyama H, Nishizaya Y, Tomita S, Inoue M. Hypoxia inducible factor-1\u03b1 is necessary for invasive phenotype in Vegf-deleted islet cell tumors. Sci Rep. 2012;2:494.","journal-title":"Sci Rep."},{"key":"1236_CR42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/315115a0","volume":"315","author":"D Hanahan","year":"1985","unstructured":"Hanahan D. Heritable formation of pancreatic \u03b2-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes. Nature. 1985;315:115\u201322.","journal-title":"Nature."},{"key":"1236_CR43","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1038\/sj.emboj.7601300","volume":"25","author":"WY Kim","year":"2006","unstructured":"Kim WY, Safran M, Buckley MR, Ebert BL, Glickman J, Bosenberg M, et al. Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo. EMBO J. 2006;25:4650\u201362.","journal-title":"EMBO J."},{"key":"1236_CR44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.pathol.2.010506.092049","volume":"2","author":"WG Kaelin","year":"2007","unstructured":"Kaelin WG. Von Hippel\u2013Lindau disease. Annu Rev Pathol. 2007;2:145\u201373.","journal-title":"Annu Rev Pathol."},{"key":"1236_CR45","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1073\/pnas.140087397","volume":"97","author":"J Peng","year":"2000","unstructured":"Peng J, Zhang L, Drysdale L, Fong GH. The transcription factor EPAS-1\/hypoxia-inducible factor 2\u03b1 plays an important role in vascular remodeling. Proc Natl Acad Sci USA. 2000;97:8386\u201391.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1236_CR46","unstructured":"Steenhard BM, Freeburg PB, Isom K, Stroganova L, Borza DB, Hudson BG St et al. Kidney development and gene expression in the HIF2\u03b1 knockout mouse. Dev. Dyn. 2007;236:1115\u201325."},{"key":"1236_CR47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1266","volume":"35","author":"M Scortegagna","year":"2003","unstructured":"Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ, et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1\u2212\/\u2212 mice. Nat Genet. 2003;35:331\u201340.","journal-title":"Nat Genet."},{"key":"1236_CR48","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/emboj\/cdg117","volume":"22","author":"M Morita","year":"2003","unstructured":"Morita M, Ohneda O, Yamashita T, Takahashi S, Suzuki N, Nakajima O, et al. HLF\/HIF-2\u03b1 is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J. 2003;22:1134\u201346.","journal-title":"EMBO J."},{"key":"1236_CR49","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1101\/gad.1399906","volume":"20","author":"KL Covello","year":"2006","unstructured":"Covello KL, Kehler J, Yu H, Gordan JD, Arsham AM, Hu CJ, et al. Hif-2\u03b1 regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 2006;20:557\u201370.","journal-title":"Genes Dev."},{"key":"1236_CR50","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","volume":"8","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin WG Jr. The von Hippel\u2013Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer. 2008;8:865\u201373.","journal-title":"Nat Rev Cancer."},{"key":"1236_CR51","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1054\/bjoc.2001.2018","volume":"85","author":"A Giatromanolaki","year":"2001","unstructured":"Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, et al. Relation of hypoxia inducible factor 1\u03b1 and 2\u03b1 in operable non-small cell lung cancer to angiogenic\/molecular profile of tumours and survival. Br J Cancer. 2001;85:881\u201390.","journal-title":"Br J Cancer."},{"key":"1236_CR52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2005.07.003","volume":"8","author":"T Acker","year":"2005","unstructured":"Acker T, Diez-Juan A, Aragones J, Tjwa M, Brusselmans K, Moons L, et al. Genetic evidence for a tumor suppressor role of HIF-2\u03b1. Cancer Cell. 2005;8:131\u201341.","journal-title":"Cancer Cell."},{"key":"1236_CR53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/blood-2008-12-193581","volume":"114","author":"N Skuli","year":"2009","unstructured":"Skuli N, Liu L, Runge A, Wang T, Yuan L, Patel S, et al. Endothelial deletion of hypoxia-inducible factor-2\u03b1 (HIF-2\u03b1) alters vascular function and tumor angiogenesis. Blood. 2009;114:469\u201377.","journal-title":"Blood."},{"key":"1236_CR54","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1172\/JCI38443","volume":"119","author":"WY Kim","year":"2009","unstructured":"Kim WY, Perera S, Zhou B, Carretero J, Yeh JJ, Heathcote SA, et al. HIF2\u03b1 cooperates with RAS to promote lung tumorigenesis in mice. J Clin Invest. 2009;119:2160\u201370.","journal-title":"J Clin Invest."},{"key":"1236_CR55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fphys.2013.00407","volume":"4","author":"MA Collins","year":"2014","unstructured":"Collins MA, di Magliano MP. Kras as a key oncogene and therapeutic target in pancreatic cancer. Front Physiol. 2014;4:407.","journal-title":"Front Physiol."},{"key":"1236_CR56","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1073\/pnas.1001296107","volume":"107","author":"J Mazumdar","year":"2010","unstructured":"Mazumdar J, Hickey MM, Pant DK, Durham AC, Sweet-Cordero A, Vachani A, et al. HIF-2\u03b1 deletion promotes Kras-driven lung tumor development. Proc Natl Acad Sci USA. 2010;107:14182\u20137.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1236_CR57","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1158\/0008-5472.CAN-13-0566","volume":"73","author":"A Criscimanna","year":"2013","unstructured":"Criscimanna A, Duan LJ, Rhodes JA, Fendrich V, Wickline E, Hartman DJ, et al. PanIN-specific regulation of Wnt signaling by HIF2\u03b1 during early pancreatic tumorigenesis. Cancer Res. 2013;73:4781\u201390.","journal-title":"Cancer Res."},{"key":"1236_CR58","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","volume":"1","author":"K Kondo","year":"2003","unstructured":"Kondo K, Kim WY, Lechpammer M, Kaelin WG Jr. Inhibition of HIF2\u03b1 is sufficient to suppress pVHL-defective tumor growth. PLoS Biol. 2003;1:E83.","journal-title":"PLoS Biol."},{"key":"1236_CR59","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1096\/fj.05-3788com","volume":"19","author":"MA Maynard","year":"2005","unstructured":"Maynard MA, Evans AJ, Hosomi T, Hara S, Jewett MA, On M. Human HIF-3\u03b14 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma. FASEB J. 2005;19:1396\u2013406.","journal-title":"FASEB J."},{"key":"1236_CR60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccr.2007.04.001","volume":"11","author":"H Zhang","year":"2007","unstructured":"Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI, et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell. 2007;11:407\u201320.","journal-title":"Cancer Cell."},{"key":"1236_CR61","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2007.02.006","volume":"11","author":"JD Gordan","year":"2007","unstructured":"Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC. HIF-2\u03b1 promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell. 2007;11:335\u201347.","journal-title":"Cancer Cell."},{"key":"1236_CR62","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1101\/gad.1024602","volume":"16","author":"TA Baudino","year":"2002","unstructured":"Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, et al. C-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev. 2002;16:2530\u201343.","journal-title":"Genes Dev."},{"key":"1236_CR63","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","volume":"151","author":"CY Lin","year":"2012","unstructured":"Lin CY, Lov\u00e9n J, Ragl PB, Paranal RM, Burge CB, Bradner JE, et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell. 2012;151:56\u201367.","journal-title":"Cell."},{"key":"1236_CR64","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrc3621","volume":"13","author":"DC Bersten","year":"2013","unstructured":"Bersten DC, Sullivan AE, Peet DJ, Whitelaw ML. bHLH-PAS proteins in cancer. Nat Rev Cancer. 2013;13:827\u201341.","journal-title":"Nat Rev Cancer."},{"key":"1236_CR65","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1073\/pnas.121494298","volume":"98","author":"B Keith","year":"2001","unstructured":"Keith B, Adelman DM, Simon MC. Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt. Proc Natl Acad Sci USA. 2001;98:6692\u20137.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1236_CR66","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1093\/nar\/gkt206","volume":"41","author":"N Hao","year":"2013","unstructured":"Hao N, Bhakti VL, Peet DJ, Whitelaw ML. Reciprocal regulation of the basic helix-loop-helix\/Per-Arnt-Sim partner proteins, Arnt and Arnt2, during neuronal differentiation. Nucleic Acids Res. 2013;41:5626\u201338.","journal-title":"Nucleic Acids Res."},{"key":"1236_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr218","volume":"124","author":"MS Denison","year":"2011","unstructured":"Denison MS, Soshilov AA, He G, DeGroot D, Zhao B. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci. 2011;124:1\u201322.","journal-title":"Toxicol Sci."},{"key":"1236_CR68","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/MCB.16.4.1706","volume":"16","author":"K Hirose","year":"1996","unstructured":"Hirose K, Morita M, Ema M, Mimura J, Hamada H, Fujii H, et al. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix\/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt). Mol Cell Biol. 1996;16:1706\u201313.","journal-title":"Mol Cell Biol."},{"key":"1236_CR69","first-page":"1674","volume":"14","author":"S Tomita","year":"2000","unstructured":"Tomita S, Sinal CJ, Yim SH, Gonzalez FJ. Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene inductionby the aryl hydroxarbon receptor and hypoxia-inducible factor 1\u03b1. Mol Endocrinol. 2000;14:1674\u201381.","journal-title":"Mol Endocrinol."},{"key":"1236_CR70","doi-asserted-by":"crossref","first-page":"17910","DOI":"10.1073\/pnas.0909353106","volume":"106","author":"K Lee","year":"2009","unstructured":"Lee K, Zhang H, Qian S, Rey DM, Liu JO, Semenza GL. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc Natl Acad Sci USA. 2009;106:17910\u20135.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1236_CR71","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00018-010-0600-7","volume":"68","author":"V Tam\u00e1si","year":"2011","unstructured":"Tam\u00e1si V, Monostory K, Prough RA, Falus A. Role ofxenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s. Cell Mol Life Sci. 2011;68:1131\u201346.","journal-title":"Cell Mol Life Sci."},{"key":"1236_CR72","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/carcin\/bgp201","volume":"30","author":"S Shi","year":"2009","unstructured":"Shi S, Yoon DY, Hodge-Bell KC, Bebenek IG, Whitekys MJ, Zhang R, et al. The aryl hydrocarbon receptor nuclear translocator (Arnt) is required for tumor initiation by benzo[a]pyrene. Carcinogenesis. 2009;30:1957\u201361.","journal-title":"Carcinogenesis."},{"key":"1236_CR73","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","volume":"22","author":"WY Kim","year":"2004","unstructured":"Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol. 2004;22:4991\u20135004.","journal-title":"J Clin Oncol."},{"key":"1236_CR74","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.molmed.2004.02.004","volume":"10","author":"MF Czyzyk-Krzeska","year":"2004","unstructured":"Czyzyk-Krzeska MF, Meller J. von Hippel\u2013Lindau tumor suppressor: not only HIF\u2019s executioner. Trends Mol Med. 2004;10:146\u20139.","journal-title":"Trends Mol Med."},{"key":"1236_CR75","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bbrc.2005.08.165","volume":"338","author":"WG Kaelin Jr","year":"2005","unstructured":"Kaelin WG Jr. The von Hippel\u2013Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem Biophys Res Commun. 2005;338:627\u201338.","journal-title":"Biochem Biophys Res Commun."},{"key":"1236_CR76","doi-asserted-by":"crossref","first-page":"e1002312","DOI":"10.1371\/journal.pgen.1002312","volume":"7","author":"LE Moore","year":"2011","unstructured":"Moore LE, Nickerson ML, Brennan P, Toro JR, Jaeger E, Rinsky J, et al. Von Hippel\u2013Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors. PLoS Genet. 2011;7:e1002312.","journal-title":"PLoS Genet."},{"key":"1236_CR77","doi-asserted-by":"crossref","first-page":"e16975","DOI":"10.1371\/journal.pone.0016975","volume":"6","author":"Y Laii","year":"2011","unstructured":"Laii Y, Qiao M, Song M, Weintraub ST, Shiio Y. Quantitative proteomics identifies the Myb-binding protein p160 as a novel target of the von Hippel\u2013Lindau tumor suppressor. PLoS One. 2011;6:e16975.","journal-title":"PLoS One."},{"key":"1236_CR78","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molcel.2006.04.006","volume":"22","author":"JS Roe","year":"2006","unstructured":"Roe JS, Kim H, Lee SM, Kim ST, Cho EJ, Youn HD. p53 stabilization and transactivation by a von Hippel\u2013Lindau protein. Mol Cell. 2006;22:395\u2013405.","journal-title":"Mol Cell."},{"key":"1236_CR79","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1073\/pnas.94.17.9102","volume":"94","author":"JR Gnarra","year":"1997","unstructured":"Gnarra JR, Ward JM, Porter FD, Wagner JR, Devor DE, Grinberg A, et al. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA. 1997;94:9102\u20137.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1236_CR80","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1073\/pnas.98.4.1583","volume":"98","author":"VH Haase","year":"2001","unstructured":"Haase VH, Glickman JN, Socolovsky M, Jaenisch R. Vascular tumors in livers with targeted inactivation of the von Hippel\u2013Lindau tumor suppressor. Proc Natl Acad Sci USA. 2001;98:1583\u20138.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1236_CR81","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-05-3241","volume":"66","author":"EB Rankin","year":"2006","unstructured":"Rankin EB, Tomaszewski JE, Haase VH. Renal cyst development in mice with conditional inactivation of the von Hippel\u2013Lindau tumor suppressor. Cancer Res. 2006;66:2576\u201383.","journal-title":"Cancer Res."},{"key":"1236_CR82","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI31581","volume":"117","author":"Y Wang","year":"2007","unstructured":"Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest. 2007;117:1616\u201326.","journal-title":"J Clin Invest."},{"key":"1236_CR83","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2337\/db08-0749","volume":"58","author":"S Puri","year":"2009","unstructured":"Puri S, Cano DA, Hebrok M. A role for von Hippel\u2013Lindau protein in pancreatic beta-cell function. Diabetes. 2009;58:433\u201341.","journal-title":"Diabetes."},{"key":"1236_CR84","doi-asserted-by":"crossref","first-page":"e4897","DOI":"10.1371\/journal.pone.0004897","volume":"4","author":"HC Shen","year":"2009","unstructured":"Shen HC, Adem A, Ylaya K, Wilson A, He M, Lorang G, et al. Deciphering von Hippel- Lindau (VHL\/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations. PLoS One. 2009;4:e4897.","journal-title":"PLoS One."},{"key":"1236_CR85","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1742-4658.2011.08022.x","volume":"278","author":"M Yang","year":"2011","unstructured":"Yang M, Chowdhury R, Ge W, Hamed RB, McDonough MA, Claridge TD, et al. Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains. FEBS J. 2011;278:1086\u201397.","journal-title":"FEBS J."},{"issue":"5556","key":"1236_CR86","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1068592","volume":"295","author":"D Lando","year":"2002","unstructured":"Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science. 2002;295(5556):858\u201361. doi: 10.1126\/science.1068592 .","journal-title":"Science."},{"key":"1236_CR87","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/bjc.2011.73","volume":"104","author":"MN Khan","year":"2011","unstructured":"Khan MN, Batthacharyya T, Andrikopoulos P, Esteban MA, Barod R, Connor T, et al. Factor inhibiting HIF (FIH) promotes renal cancer cell survival by protecting cells from HIF-1\u03b1-mediated apoptosis. Br J Cancer. 2011;104:1151\u20139.","journal-title":"Br J Cancer."},{"key":"1236_CR88","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.canlet.2013.01.003","volume":"331","author":"L Zhang","year":"2013","unstructured":"Zhang L, Sun ZJ, Bian Y, Kulkarni AB. MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. Cancer Lett. 2013;331:230\u20138.","journal-title":"Cancer Lett."},{"key":"1236_CR89","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0006-291X(02)00862-8","volume":"296","author":"F Oehme","year":"2002","unstructured":"Oehme F, Ellinghaus P, Kolkhof P, Smith TJ, Ramakrishan S, H\u00fctter J, et al. Overexpression of PH-4, a novel putative 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem Biophys Res Commun. 2002;296:343\u20139.","journal-title":"Biochem Biophys Res Commun."},{"key":"1236_CR90","doi-asserted-by":"crossref","first-page":"30544","DOI":"10.1074\/jbc.M704988200","volume":"282","author":"P Koivunen","year":"2007","unstructured":"Koivunen P, Tiainen P, Hyv\u00e4rinen J, Williams KE, Sormunen R, Klaus SJ, et al. An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor \u03b1. J Biol Chem. 2007;282:30544\u201352.","journal-title":"J Biol Chem."},{"key":"1236_CR91","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1073\/pnas.0601283103","volume":"103","author":"MA McDonough","year":"2006","unstructured":"McDonough MA, Li V, Flashman E, Chowdhury R, Mohr C, Li\u00e9nard BM, et al. Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2). Proc Natl Acad Sci USA. 2006;103:9814\u20139.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1236_CR92","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1016\/j.str.2009.06.002","volume":"17","author":"R Chowdhury","year":"2009","unstructured":"Chowdhury R, McDonough MA, Mecinovi\u0107 J, Loenarz C, Flashman E, Hewitson KS, et al. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases. Structure.\u00a02009;17:9891\u20139.","journal-title":"Structure."},{"key":"1236_CR93","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2353\/ajpath.2009.080687","volume":"174","author":"J Sch\u00f6del","year":"2009","unstructured":"Sch\u00f6del J, Klanke B, Weidemann A, Buchholz B, Bernhardt W, Bertog M, et al. HIF-prolyl hydroxylases in the rat kidney: physiologic expression patterns and regulation in acute kidney injury. Am J Pathol. 2009;174:1663\u201374.","journal-title":"Am J Pathol."},{"key":"1236_CR94","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2007-10-117812","volume":"111","author":"YJ Minamishima","year":"2007","unstructured":"Minamishima YJ, Moslehi J, Bardeesy N, Cullen D, Bronson RT, Kaelin WG Jr. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood. 2007;111:3236\u201344.","journal-title":"Blood."},{"key":"1236_CR95","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","volume":"22","author":"E Berra","year":"2003","unstructured":"Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1\u03b1 in normoxia. EMBO J. 2003;22:4082\u201390.","journal-title":"EMBO J."},{"key":"1236_CR96","doi-asserted-by":"crossref","first-page":"38183","DOI":"10.1074\/jbc.M302244200","volume":"278","author":"G D\u2019Angelo","year":"2003","unstructured":"D\u2019Angelo G, Duplan E, Boyer N, Vigne P, Frelin C. Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation. J Biol Chem. 2003;278:38183\u20137.","journal-title":"J Biol Chem."},{"key":"1236_CR97","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1158\/0008-5472.CAN-09-1876","volume":"70","author":"AT Henze","year":"2010","unstructured":"Henze AT, Riedel J, Diem T, Wenner J, Flamme I, Pouyseggur J, et al. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Cancer Res. 2010;70:357\u201366.","journal-title":"Cancer Res."},{"key":"1236_CR98","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1582-4934.2010.01030.x","volume":"14","author":"T Jokilehto","year":"2010","unstructured":"Jokilehto T, Jaakkola PM. The role of HIF prolyl hydroxylases in tumour growth. J Cell Mol Med. 2010;14:758\u201370.","journal-title":"J Cell Mol Med."},{"key":"1236_CR99","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cell.2009.01.020","volume":"136","author":"M Mazzone","year":"2009","unstructured":"Mazzone M, Dettori D, de Oliveira RL, Loges S, Schmidt T, Jonckx B, et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell. 2009;136:839\u201351.","journal-title":"Cell."},{"key":"1236_CR100","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1158\/0008-5472.CAN-10-3838","volume":"71","author":"A Klotzsche von-Ameln","year":"2011","unstructured":"Klotzsche von-Ameln A, Muschter A, Mamlouk S, Kalucka J, Prade I, Franke K, et al. Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGF\u03b2. Cancer Res. 2011;71:3306\u201316.","journal-title":"Cancer Res."},{"key":"1236_CR101","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1158\/1078-0432.CCR-07-5258","volume":"14","author":"A Couvelard","year":"2008","unstructured":"Couvelard A, Deschamps L, Rebours V, Sauvanet A, Gatter K, Pezzella F, et al. Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3 and FIH is associated with tumor aggressiveness in pancreatic endocrine tumors. Clin Cancer Res. 2008;14:6634\u20139.","journal-title":"Clin Cancer Res."},{"key":"1236_CR102","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1365-2559.2010.03566.x","volume":"56","author":"L Gossage","year":"2010","unstructured":"Gossage L, Zaitoun A, Fareed KR, Turley H, Aloysius M, Lobo DN, et al. Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancer. Histopathology. 2010;56:908\u201320.","journal-title":"Histopathology."},{"key":"1236_CR103","doi-asserted-by":"crossref","first-page":"8336","DOI":"10.1128\/MCB.00425-06","volume":"26","author":"K Takeda","year":"2006","unstructured":"Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, Fong GH. Placental but not heart defects are associated with elevated hypoxia-inducible factor \u03b1 levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol. 2006;26:8336\u201346.","journal-title":"Mol Cell Biol."},{"key":"1236_CR104","doi-asserted-by":"crossref","first-page":"33571","DOI":"10.1074\/jbc.M113.482364","volume":"288","author":"PR Arsenault","year":"2013","unstructured":"Arsenault PR, Pei F, Lee R, Kerestes H, Percy MJ, Keith B, et al. A Knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism. J Biol Chem. 2013;288:33571\u201384.","journal-title":"J Biol Chem."},{"key":"1236_CR105","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1161\/CIRCULATIONAHA.110.014019","volume":"124","author":"M Huang","year":"2011","unstructured":"Huang M, Nguyen P, Jia F, Hu S, Gong Y, de Almeida PE, et al. Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicyrcle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarctation. Circulation. 2011;124:S46\u201354.","journal-title":"Circulation."},{"key":"1236_CR106","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4161\/cbt.13.4.18830","volume":"13","author":"A Klotzsche-von Ameln","year":"2012","unstructured":"Klotzsche-von Ameln A, Muschter A, Heimesaat MM, Breier G, Wielockx B. HIF prolyl hydroxylase-2 inhibition diminishes tumor growth through matrix metalloproteinase-induced TGF\u03b2 activation. Cancer Biol Ther. 2012;13:216\u201323.","journal-title":"Cancer Biol Ther."},{"key":"1236_CR107","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ijc.28409","volume":"134","author":"S Mamlouk","year":"2014","unstructured":"Mamlouk S, Kalucka J, Singh RP, Franke K, Muschter A, Langer A, et al. Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development. Int J Cancer. 2014;134:849\u201358.","journal-title":"Int J Cancer."},{"key":"1236_CR108","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1158\/1541-7786.MCR-07-2113","volume":"6","author":"KA Lee","year":"2008","unstructured":"Lee KA, Lynd JD, O\u2019Reilly S, Kiupel M, McCormick JJ, LaPres JJ. The biphasic role of the hypoxia-inducible factor prolyl-4-hydroxylase, PHD2, in modulating tumor-forming potential. Mol Cancer Res. 2008;6:829\u201342.","journal-title":"Mol Cancer Res."},{"key":"1236_CR109","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ccr.2009.04.010","volume":"15","author":"DA Chan","year":"2009","unstructured":"Chan DA, Kawahara TLA, Sutphin PD, Chang HY, Chi JT, Giaccia AJ. Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Cancer Cell. 2009;15:527\u201338.","journal-title":"Cancer Cell."},{"key":"1236_CR110","doi-asserted-by":"crossref","first-page":"e23847","DOI":"10.1371\/journal.pone.0023847","volume":"6","author":"S Andersen","year":"2011","unstructured":"Andersen S, Donnem T, Stenvold H, Al-Saad S, Al-Shibli K, Busund LT, et al. Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival. PLoS One. 2011;6:e23847.","journal-title":"PLoS One."},{"key":"1236_CR111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drup.2003.12.004","volume":"7","author":"BG Wouters","year":"2004","unstructured":"Wouters BG, van den Beucken T, Magagnin MG, Lambin P, Koumenis C. Targeting hypoxia tolerance in cancer. Drug Resis Updat. 2004;7:25\u201340.","journal-title":"Drug Resis Updat."},{"key":"1236_CR112","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng.2007.62","volume":"40","author":"J Aragon\u00e9s","year":"2008","unstructured":"Aragon\u00e9s J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M, et al. Deficiency or inhibition of oxygen sensor Phd1 induces hipoxia tolerance by reprogramming basal metabolism. Nat Genet. 2008;40:170\u201380.","journal-title":"Nat Genet."},{"key":"1236_CR113","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1152\/japplphysiol.01324.2004","volume":"99","author":"J Magalh\u00e3es","year":"2005","unstructured":"Magalh\u00e3es J, Ascens\u00e3o A, Soares JM, Ferreira R, Neuparth MJ, Marques F, et al. Acute and severe hypobaric hypoxia increases oxidative stress and impairs mitochondrial function in mouse skeletal muscle. J Appl Physiol. 2005;99:1247\u201353.","journal-title":"J Appl Physiol."},{"key":"1236_CR114","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1053\/j.gastro.2009.09.057","volume":"138","author":"M Schneider","year":"2010","unstructured":"Schneider M, Van Geyte K, Fraisl P, Kiss J, Aragon\u00e9s J, Mazzone M, et al. Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia\/reperfusion injury. Gastroenterology. 2010;138:1143\u201354.","journal-title":"Gastroenterology."},{"key":"1236_CR115","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1128\/MCB.01231-07","volume":"28","author":"O Kikhaylova","year":"2008","unstructured":"Kikhaylova O, Ignacak ML, Barankiewicz TJ, Harbaugh SV, Yi Y, Maxwell PH, et al. The von Hippel\u2013Lindau tumor suppressor protein and Egl-9-type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress. Mol Cell Biol. 2008;28:2701\u201317.","journal-title":"Mol Cell Biol."},{"key":"1236_CR116","first-page":"8777","volume":"63","author":"N Erez","year":"2003","unstructured":"Erez N, Milyavsky M, Eilam R, Shats I, Goldfinger N, Rotter V. Expression of prolyl-hydroxylase-1 (PHD1\/EGLN2) suppresses hypoxia inducible factor-1\u03b1 activation and inhibits tumor growth. Cancer Res. 2003;63:8777\u201383.","journal-title":"Cancer Res."},{"key":"1236_CR117","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/j.gastro.2009.09.049","volume":"138","author":"J Xue","year":"2010","unstructured":"Xue J, Li X, Jiao S, Wei Y, Wu G, Fang J. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKK\u03b2 independent of hydroxylase activity. Gastroenterology. 2010;138:606\u201315.","journal-title":"Gastroenterology."},{"key":"1236_CR118","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/sj.bjc.6605936","volume":"103","author":"Y Su","year":"2010","unstructured":"Su Y, Loos M, Giese N, Hines OJ, Diebold I, G\u00f6rlach A, et al. PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer. Br J Cancer. 2010;103:1571\u20139.","journal-title":"Br J Cancer."},{"key":"1236_CR119","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1128\/MCB.00331-09","volume":"29","author":"YA Minamishima","year":"2009","unstructured":"Minamishima YA, Moslehi J, Padera RF, Bronson RT, Liao R, Kaelin WG Jr. A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol Cell Biol. 2009;29:5729\u201341.","journal-title":"Mol Cell Biol."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1236-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-014-1236-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1236-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T20:16:11Z","timestamp":1650485771000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-014-1236-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,29]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["1236"],"URL":"https:\/\/doi.org\/10.1007\/s12094-014-1236-0","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,29]]}}}